Trials / Completed
CompletedNCT00457275
Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)
A Multicentre, Open-Label, Observational Local Study to Evaluate the LDL-C Lowering Effect of Ezetimibe as Prescribed in Daily Routine Practice in the South African Population
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 440 (planned)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the LDL-C lowering in south african patients with primary hypercholesterolaemia after the addition of ezetimibe 10mg /day to ongoing therapy with a statin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653, ezetimibe / Duration of Treatment: 4 Weeks |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2007-04-06
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00457275. Inclusion in this directory is not an endorsement.